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Abstract: 
In spite of availability of moderately protective vaccine and antibiotics, new antibacterial agents are urgently needed to decrease 
the global incidence of Klebsiella pneumonia infections. MurF ligase, a key enzyme, which participates in the bacterial cell wall 
assembly, is indispensable to existence of K. pneumonia. MurF ligase lack mammalian vis-à-vis and have high specificity, 
uniqueness, and occurrence only in eubacteria, epitomizing them as promising therapeutic targets for intervention. In this study, 
we present a unified approach involving homology modeling and molecular docking studies on MurF ligase enzyme. As part of 
this study, a homology model of K. pneumonia (MurF ligase) enzyme was predicted for the first time in order to carry out structure-
based drug design. The accuracy of the model was further validated using different computational approaches. The comparative 
molecular docking study on this enzyme was undertaken using different phyto-ligands from Desmodium sp. and a known antibiotic 
Ciprofloxacin. The docking analysis indicated the importance of hotspots (HIS 281 and ASN 282) within the MurF binding pocket. 
The Lipinski’s rule of five was analyzed for all ligands considered for this study by calculating the ADME/Tox, drug likeliness 
using Qikprop simulation. Only ten ligands were found to comply with the Lipinski rule of five. Based on the molecular docking 
results and Lipinki values 6-Methyltetrapterol A was confirmed as a promising lead compound. The present study should 
therefore play a guiding role in the experimental design and development of 6-Methyltetrapterol A as a bactericidal agent. 
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Background: 
Klebsiella pneumonia (KN) belonging to the enterobacteriaceae 
family is a gram-negative, rod-shaped, non-motile, 
encapsulated bacterial pathogen. Its continued global challenge 
has precipitated the emergence of pandrug-resistant clones to 
clinically pertinent antibiotics (e.g. Fluroquinones, third-
generation cephalosporins and carbapenems) that resulted in 
limited therapeutic strategies t o  c o m b a t  t h i s  p a t h o g e n  [1-3]. 
Hence, the compelling need to develop novel and potent anti-
bacterial drugs to overcome this pathogen is of global concern 
and national importance. Most of the antibiotics designed by 
the researchers over last five decades have focused on either 
improving the design or structure of an agent that could 
intervene with the peptidoglycan biosynthesis process or inhibit 
a key enzyme involved in its assembly [4]. Peptidoglycan layer 
is considered to be indispensable to bacterial cell wall providing 
it structural integrity and protection against osmotic pressure. 
The peptidoglycan biochemical assembly involves both BIOINFORMATION  open access 
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extracellular and intracellular pathways [4]. Among them only 
the extracellular pathway has been extensively studied and 
over-exploited for anti-bacterial intervention. The intracellular 
stage of peptidoglycan biosynthesis involving the ATP-
dependent Mur ligases (MurC, MurD, MurE and MurF) have 
been least studied [4]. Hence to explore this (MurF) pathway of 
KN as an option for bactericidal drug development the present 
study was undertaken.  
 
MurF catalyzes the last cytoplasmic step of ligation of D-Ala-
DAla to UDP-MurNAc-tripeptide (UDP-MurNAc-L-Ala-γ-D-
Glu-meso-diaminopimelate), with hydrolysis of ATP resulting 
in synthesis of UDP-MurNAc-pentapeptide [4]. MurF lacks 
human counterparts and are unique and highly conserved 
among various bacterial species rendering them as promising 
therapeutic targets for intervention. Due to the above 
mentioned reason, a potential MurF inhibitor would be 
expected to be bactericidal and to have a wide spectrum action 
against gram negative pathogens, which validates its choice as a 
target for the development of new inhibitors/bactericidals [5]. 
The search for new biologically active compounds from natural 
sources is currently of great interest as they are the parent 
compounds for most of presently available commercial 
bactericidal agents/inhibitors/antibiotics. Numerous in vitro 
(10 µM < IC 50 > 20 µM) reports suggest the aqueous, alcoholic 
and acetone extracts of Desmodium plant sp. possesses potential 
bactericidal activity against enterobacteriaceae family of 
pathogens. Desmodium flora species have a long history of being 
used in Indian ayurvedic medicine and Chinese traditional 
medicine against such enterobacteriaceae pathogens [6]. Here, we 
chose few recently reported phyto-ligands from this plant for 
our structure based drug designing (SBDD) study, viz., 6-
Methyltetrapterol A (6MT), Uncinanone A, Uncinanone B, 
Uncinanone C, Uncinanone D, Uncinanone E, Quercetin, 
Hydnocarpin, Edudiol, Hydroxydesmodian B, Desmodol, 
Desmodian C, Desmodian D and Yukovanol [6].  
 
Virtual screening has become increasingly popular in hit 
discovery and lead compound optimization. Comparisons 
based on Lipinski analysis for all phyto-ligands were pursued 
to suggest the drug likeliness of active principles/phytoligands 
of Desmodium plant sp considered for this study. The results of 
in silico interactions studies of MurF with all the above 
mentioned phyto-ligands were compared with interactions of 
Ciprofloxacin (CP - Fluroquinone drug used as last resort broad 
spectrum anti-bacterial agent) to show the bactericidal potency 
of the phyto-ligands. The primary objective of the present work 
is to report the three-dimensional model of KN-MurF enzyme 
for the first time. KN-MurF provides the geometry of hot spot 
regions, i.e., binding site residues, and therefore provides a 
clear insight into the importance of the active site residues in 
terms of their contribution to protein-ligand complexes. 
Moreover, the rational design of an inhibitor selective towards 
the KN-MurF enzyme could be more effective if the key 
residues and atomic level binding site interactions are known. 
A unified approach involving homology modeling, molecular 
docking and electrostatic potential analysis was applied to KN-
MurF to probe its active site residues, interactions, thereby 
revealing its mechanism of action. 
 
Methodology: 
All computations and SBDD of KN-MurF enzyme were carried 
out on a Pentium IV Dual Core processor workstation with 
Windows 7 operating system using Accelrys Draw (v4.0), 
Autodock (v4.2), Schrödinger (v9.2), Swiss-PdbViewer (v4.04) 
and Chimera (v1.5.3) molecular modeling packages [7-10]. 
 
Sequence analysis and physiochemical characterization 
KN-MurF Ligase protein sequence (ID: A6T4M9) was retrieved 
from Uniprot database in FASTA format. Its physiochemical 
characterization was computed using the Expasy Protparam 
program. Secondary structure prediction analysis was 
performed using SABLE program [11]. Template (Escherichia 
coli-MurF: 1GG4_A) was selected by performing BLAST search 
against protein databank (PDB) with > 80% sequence identity 
cut off for homology modeling. Alignment between target KN 
sequence (KN-MurF Ligase) and the template Escherichia coli 
(EC) sequence (EC-MurF Ligase, PDB ID: 1GG4_A) was 
performed with Multalin tool and visualized using ES pript [12, 
13]. 
 
Homology modeling and validation 
Tertiary structure prediction was performed using I-Tasser 
Server for homology modeling [14]. The plausible models of 
KN-MurF obtained from I-Tasser server were verified by 
Structural Analysis and Verification Server (SAVES) to evaluate 
its stereo-chemical quality [15, 16].  
 
Ligand preparation and ADME/Tox Prediction 
The structures of 14 phyto-ligands and 1 antibiotic, 
Ciprofloxacin, were sketched with Accelrys Draw (v4.0). Each 
structure was launched in ligprep (Schrödinger) and energy 
minimized using the OPLS force field and geometrically 
optimized followed by Lipinski’s values/ADME-Tox prediction 
by using Qikprop (Schrödinger). 
 
Molecular Docking 
Docking analysis of KN-MurF1 was carried out using Autodock 
(v4.2) with the aim of exposing the active site amino acid 
residues involving protein-ligand interactions so as to obtain 
information about the bioactive conformation of these KN-
MurF inhibitors. From the ADT package hydrogen atoms were 
added, Nonpolar hydrogens and lone pairs were merged and 
each atom within the macromolecule was assigned a Gasteiger 
partial charge. A grid box of 80×80×80, with a spacing of 0.447 
Å was positioned using autogrid and blind docking was 
performed. The Lamarckian genetic algorithm (LGA) of up to 
20 runs was employed with the settings of population size of 
150 individuals, maximum number of generations and energy 
evaluations of 27,000 and 2.5 million respectively. From the 
estimated free energy of ligand binding (ΔG), the inhibition 
constant (Ki) for each ligand was calculated. Ki is calculated by 
the equation: Ki =exp [(ΔG* 1000)/ (R*T)] Where ΔG is docking 
energy, R (gas constant) is 1.98719 cal K−1 mol−1 and T 
(Temperature) is 298.15 K. Only the best pose (the one with the 
lowest binding energy) was considered for each ligand. All 
previously mentioned phyto-ligands after ligand preparation 
were docked successfully in the active site of the model KN-
MurF1 enzyme. Molecular visualization of the docked 
complexes was carried out with Chimera (v1.5.3).  
 
Molecular electrostatic potential analysis 
The Molecular electrostatic potential (MEP) analysis at the 
functional binding pocket of KN-MurF1-6-MT complex and 
KN-MurF1-CP complex were carried out using Swiss-
PdbViewer (v4.04) to visually compare two molecules with its BIOINFORMATION  open access 
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ligands based on their surface level potential values. To both 
structures Poisson-Boltzmann based molecular surface was 
generated and visualized independently. 
 
 
Figure 1: The alignment between target and template sequence  
 
Discussion: 
The physiochemical characterization of KN-MurF protein 
revealed the following: Sequence length (452 amino acid 
residues); Molecular weight (47.5 KDa); Theoretical Iso-electric 
point (5.53); Major residues (Ala 15.7% and Leu 10.8%); Total 
number of negatively charged residues (Asp + Glu): 46; Total 
number of positively charged residues (Arg + Lys): 36; 
Extinction coefficient (33835 M-1 cm-1); Instability index (25.81); 
Aliphatic index (98.54) and Grand average of hydropathicity 
(GRAVY): 0.118.  
 
Secondary analysis of KN-MurF revealed presence of 42.92% α-
helix (H), 19.9% β-sheets (E) and 28% random coils (C). In the 
absence of experimental data, structure-building on the basis of 
known 3D structure (template) of a homologous protein is the 
only plausible method to obtain structural information which is 
based on sequential information [17]. The blastp results of KN-
MurF revealed the availability of crystal structure of MurF 
(1GG4_A: Resolution 2.3 Å) from closely homologous 
bacterium E. Coli (EC) [18]. Hence, EC-MurF (PDB ID: 1GG4_A) 
was chosen as template to predict target KN-MurF (A6T4M9) 
structure due to global sequence similarity of 80% between two 
sequences,  higher coverage >90% of aligned sequence, with 
least E-value (0) and higher score (721) than other PDB hits.  
 
Since, the quality of the 3D structure of a modeled protein 
strongly depends on the accuracy of the template structure 
chosen; multiple sequence alignment (MSA) was undertaken. 
MSA between target (KN-MurF: A6T4M9) and template (EC-
MurF: 1GG4_A) sequence was performed to identify the 
sequence-structure relationship (Figure 1) It was found that 
approximately > 80% of the amino acid residues are highly 
conserved between them including the active site region 
containing residues PRO278, HIS281 and ASN282 (shown as 
marked boxes).  
 
 
Figure 2: Target models of K. pneumonia (MurF Ligase): KN-
MurF1 (2a) and KN-MurF2 (2b) illustrated as ribbon structure 
with RGB (red, green and blue) colours along with its shadow 
as hydrophobic surface. (D1-D3) represents three consecutive 
open alpha/beta-sheet domains. C and N represent C-Terminal 
and N-Terminal respectively 
 
I-Tasser a web based structure prediction program was used in 
this study for performing template (EC-MurF) based homology 
modelling approach of target (KN-MurF). I-Tasser generated 
two plausible models KN-MurF1 and KN-MurF2 (Figure 2a & 
2b). Three criteria (C-Score, TM score and RMSD values) were 
employed to compare the quality of predicted models to choose 
the best one. KN-MurF1 homology model was predicted to 
have a C-Score 1.21 which was comparatively better than KN-
MurF2 homology model C-Score of 0.22. The estimated 
computational TM score (0.94±0.05) and RMSD (3.8±0.2A°) of 
KN-MurF1 too was found to be better than the values obtained 
for KN-MurF2 model. KN-MurF1 expeditiously qualified all the 
three criteria signifying its quality as the best model. 
 
Ramachandran plot computed by PROCHECK module of 
SAVES showed that only 0.3% of residues existed in disallowed 
regions confirming the quality of KN-MurF1 predicted to be 
highly significant (Figure 3a). ERRAT analysis showed the 
overall structural quality of the predicted structure as 95.64, 
which is very good experimentally and computationally (Figure 
3b). VERIFY_3D analysis showed that 98.44% of KN-MurF1 
protein residues had an average 3D-1D score > 0.2 showing 
good primary sequence to tertiary structure compatibility. BIOINFORMATION  open access 
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Evaluation of KN-MurF1 structural quality with ProSA-web 
reveals that its ProSA Z-score value −9.22 falls in the range of 
native conformations computed using X-ray crystallography 
method represented as encircled large black dot (Figure 3c). 
The results reveal that most of the residues fall in the negative 
energy minima region representing good structural quality and 
low energy levels of the predicted protein KN-MurF1 (Figure 
3d). Thus the various approaches elaborate the highly 
dependable quality and stability of predicted KN-MurF1 3D 
structure. 
 
Figure 3: Stereo-chemical validation of the predicted KP-MurF1 
is shown below using Ramachandran plot and its statistics from 
Procheck  (3a), ERRAT plot (3b), ProSA Z-score (3c) and 
corresponding energy schema (3d). 
 
ADME-Tox/Lipinski’s rule of five (molecular weight < 500 Da, 
HB donor < 5, HB acceptor < 10 and QPlogPo/w 
(octanol/water partition coefficient) should be < 5) for all 14 
phyto-ligands and Ciprofloxacin (CP) were generated Table 2 
(see supplementary material). Out of the 14 phyto-ligands 
Hydnocarpin, Uncinanone A, Uncinanone B, 
Hydroxydesmodian B and Desmodian D failed to obey the 
Lipinski’s rule of five since the number of acceptor HB were 
greater than 10. All the other phyto-ligands including CP 
comply with the Lipinski’s rule of five. Hence only the rest ten 
ligands inclusive of ciprofloxacin were further considered for 
docking studies Table 1 (see supplementary material). The 
docking analysis revealed the presence of GLU116, PRO278, 
HIS281, ASN 282, GLN 311, VAL313, ARG316, LEU317 and 
SER339 residues within the vicinity of 4Å of active site of KN-
MurF1. The docking results further confirmed 6-
Methyltetrapterol A (6MT) as the best lead molecule due to its 
least docking energy, lowest Ki value and involves 3 hydrogen 
bond (HB) interactions with hotspot residues PRO278, HIS281 
and ASN282 of KN-MurF1 active site as compared to other 
ligands  Figure 4 & Table 2 (see supplementary material).  
 
 
Figure 4: KN-MurF1-6-MT complex (4a) and KN-MurF1-CP 
complex  (4c) with their corresponding interaction residues 
within 4Å vicinity of active site hotspots (4b & 4d). 6MT- Blue 
colour and CP- Pink colour represented as a ball and stick 
model. 
 
The docking interaction complex KN-MurF1-6MT was 
compared with KN-MurF1-CP (3a-3d). The active site 
interaction was magnified to understand the molecular 
conformations of ligands (CP and 6MT) docking with receptor 
KN-MurF1 and to gain knowledge on the ligand-receptor HB 
interaction (light brown colour) within the vicinity of 4 Å of 
active site hot spot region (Figure 4b & 4d). KN-MurF1-6MT 
complex involves three HB interactions at PRO278, HIS281 and 
ASN 282 residues with a better ΔG score and least Ki Value as 
compared to two hydrogen bond interactions at GLU116 and 
HIS 281 and higher ΔG score and Ki Value of KN-MurF1-CP 
complex. Almost 90 degree conformational orientation of the 
two primary rings of ligand 6MT as compared to CP expanded 
KN-MurF1 active site resulting in accessing the ASN282 residue 
for HB interaction. The smaller ring structure of CP resulted in 
only partially accessing the active site resulting in the 
prevention of access to ASN282 as evident from the molecular 
surface information of both the complexes. 
 
MEP represents the non-bonded interaction energy between 
ligands and receptors [19]. Hence, it was calculated for both the 
complexes to compare their ligand docking regions. The ligand 
docking region cleft (encircled with an arrow) of KN-MurF1-
6MT is completely engulfed by a positive charge whereas in 
case of KN-MurF1-CP the ligand docking region is only 
partially engulfed by a positive charge (Figure 5a & 5b). Thus, 
there is clear evidence of differences in their charge 
complementarity indicating tighter binding in KN-MurF1-CP 
than in KN-MurF1-6MT. Thus, MEPS analysis revealed basic 
differences in the ligand binding pocket, which could be BIOINFORMATION  open access 
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exploited in future for the rational design of selective KN-MurF 
bactericidals. 
 
 
Figure 5: Molecular surface representation of KN-MurF1-6-MT 
Complex  (5a) and KN-MurF1-CP Complex (5b) and their 
respective MEP represented as blue mesh (positive potential) 
and red mesh (negative potential). The encircled region 
represents their corresponding active site region. 
 
Conclusion: 
The KN-MurF homology model generated for the first time a 
3D structural model that can be used for screening different 
molecules for KN-specific MurF inhibitory activity. The 
developed model showed good overall structural quality and 
was confirmed using several different validation tools. Our 
study provided structural insight about the hotspots HIS 281 
and ASN 282 and their corresponding plausible potential 
charge interactions with ligands. Thus, the present work forms 
the basis for further molecular modeling and biochemical 
studies on targeting the KN-MurF enzyme for therapy. Our 
studies conclusively revealed 6-MT as a potent lead compound 
better than other ligands based on best values of docking 
energy, Ki value and HB interactions. Further, pre-clinical 
analysis of 6-MT is necessary to accurately understand its 
molecular mechanism of action and pharmacological efficiency 
to conclusively state it as an anti-bacterial analogue. 
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Supplementary martial: 
 
Table 1: Lipinski values/ADME-Tox of Desmodium sp. phyto-ligands and Ciprofloxacin along with their structural representations 
S. No  Compounds  Structures  Donor HB  Accpt HB  Mol MW  QPlog Po/w 
1 6-Methyltetrapterol  A 
 
4 9.25  452.63  2.89 
2 Uncinanone  B    5  10.2  372.501  1.043 
3 Quercetin    5  7  302.23  1.683 
4 Yukovanol    4  9.25  370.485  1.434 
5 Hydnocarpin 
 
5 15.3  486.601  0.469 
6 Uncinanone  E    2  4.75  436.504  4.395 
7 Desmodol 
 
4 9.25  384.512  1.625 BIOINFORMATION  open access 
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8 Edudiol    2  8.5  368.512  2.563 
9 Desmodian  C    1  6.8  380.567  4.232 
10 Uncinanone  A 
 
5 10.2  372.501  1.043 
11 Hydroxydesmodian  B    2  10.2  412.565  2.84 
12 Uncinanone  D    2  8.5  426.635  3.985 
13 Ciprofloxacin 
 
1 6  331.346  0.28 
14 Desmodian  D    4  10.95  400.511  1.355 
15 Uncinanone  C 
 
4 9.2  383.411  3.202 BIOINFORMATION  open access 
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Table 2: Docking studies of Desmodium plant species derivatives with modelled MurF compared against Ciprofloxacin-MurF 
complex. 
S.NO COMPOUNDS  ΔG (KCAL MOL−1) 
INHIBITORY 
CONSTANT Ki (µM)  H-BOND INTERACTION  DISTANCE (Å)  
1 6-Methyltetrapterol 
A 
-8.7  1.22  PRO 278 O-H...O 
HIS 281 N-H...O 
ASN 282 O-H...O 
2.140 
2.048 
3.711 
2 Quercetin  -7.85  1.76  THR428  O-H...O 
THR260 O-H...O 
GLU349 O-H...O 
1.668 
1.697 
1.81 
3 Yukovanol  -7.84  1.79  ALA312  N-H...O 
PRO276 O-H...O 
1.927 
1.771 
4  Uncinanone E  -7.72  5.03  VAL313 N-H...O 
ARG316 N-H...O 
2.197 
1.993 
5 Desmodol  -7.56  2.89  ASN334  O-H...O 
ASN334O-H...O 
2.077 
1.853 
6  Uncinanone C  -7.0  7.35  ARG316 O-H...O  2.065 
7 Edudiol  -6.93  8.28  HIS281  N-H...O 
PRO278 O-H...O 
ARG316 N-H...O 
1.901 
1.877 
2.223 
8 DesmodianC  -6.74  11.42  SER325  N-H..O  1.93 
9 Ciprofloxacin  -6.2  28.76  GLU116  O-H...O 
HIS 281 N-H...O 
1.892 
3.371 
10 Uncinanone  D  -5.93  45.04  HIS281  N-H...O  2.041 
 